AGP Picks
View all

Somaliland Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Somaliland Health Watch.

Press releases published on October 15, 2026

The C-Section Recovery High-Waist Underwear Market Shows Promising Growth Prospects with an 8.4% CAGR Expected
Colon Cleanse Guide From Certified Colon Therapist Clarifies 15 Day Colon Detox Protocol
Alignment Health Expands Medicare Advantage Coverage to San Antonio for 2027
Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement
Clever Care Health Plan Introduces Expanded 2027 Medicare Advantage Benefits Package to Enhance Strong Member Experience
UAE Banking Heavyweight Joins NeOnc as Global Brain-Cancer Drug Development Advances
Novonesis Opens Doors to Students to Inspire the Next Generation of U.S. Biomanufacturing Talent
Vivos Therapeutics Agrees to Acquire Minority Stake in SOD Sciences and 50% Interest in Proprietary Pseudohypoxia Test
OneMedNet Adds Leading Hospital System Provider Network, Expanding By Up to 12 Hospitals
Sienna Announces October Dividend
TOMI Environmental Solutions Reports Independent Lab Results Showing SteraMist iHP Is Effective Against Listeria Biofilm, a Leading Cause of Food Recalls
NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine
Recursion Announces $200 Million Oversubscribed Follow-On Offering, Clinical Data Updates, and Partnership Milestone
Eyonis to Present Clinical Evidence for AI-Powered Lung Cancer Screening at CHEST 2026
Henlius’ HANDAYUAN (Adalimumab Biosimilar) Secures DRAP Approval in Pakistan, Marking Its First Overseas Approval
Daxor Accelerates Commercial Expansion of Next-Gen Blood Volume Diagnostic Platform at MedAxiom CV Transforum Fall '26
Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026
Nema Health Expands Access to Specialized PTSD Treatment Through Evernorth Behavioral Health Network
IRulya Therapeutics to Participate in the Craig-Hallum Biotech Catalyst Conference
Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Somaliland Health Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.